Literature DB >> 2482310

Interferon in pregnancy.

T Chard1.   

Abstract

The cells of the immune system exchange information by a complex network of molecules referred to as lymphokines: these include the interferons. The physiology of the interferons, both in terms of control and function, is poorly understood. However, there is ample evidence that production of alpha-interferon is characteristic of the fetoplacental unit in both the human and other species. Indeed, the major trophoblast protein in early pregnancy in the sheep is alpha-interferon and in this species the molecule appears to have an important anti-luteolytic effect. The function of the interferons in human pregnancy is not known but, by analogy with information from other experimental systems, it might reflect aspects of the immune relationship between the mother and the fetus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482310

Source DB:  PubMed          Journal:  J Dev Physiol        ISSN: 0141-9846


  3 in total

1.  Experimental study of transplacental passage of alpha interferon by two assay techniques.

Authors:  A Waysbort; M Giroux; V Mansat; M Teixeira; J C Dumas; J Puel
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

2.  The danger of studying human chorionic gonadotrophin action or expression in animal models.

Authors:  R K Iles
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

3.  Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.

Authors:  Marta Giannini; Emilio Portaccio; Angelo Ghezzi; Bahia Hakiki; Luisa Pastò; Lorenzo Razzolini; Elisa Piscolla; Laura De Giglio; Carlo Pozzilli; Damiano Paolicelli; Maria Trojano; Maria Giovanna Marrosu; Francesco Patti; Loredana La Mantia; Gianluigi Mancardi; Claudio Solaro; Rocco Totaro; Maria Rosaria Tola; Giovanna De Luca; Alessandra Lugaresi; Lucia Moiola; Vittorio Martinelli; Giancarlo Comi; Maria Pia Amato
Journal:  BMC Neurol       Date:  2012-10-22       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.